Overview

Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
An open label study in 40-60 subjects with diagnosed lung airway disease and in 10-20 normal controls. Each subject will receive PFP as a contrast agent to visualize the airway and alveolar spaces in their lungs using magnetic resonance imaging of inert gas/oxygen mixtures.
Phase:
Phase 1
Details
Lead Sponsor:
Hal C Charles